Spleen index in an IMQ-induced psoriasis mouse model
Animal study · BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group [1]
In BALB/c mice with IMQ-induced psoriasis, clobetasol propionate was applied topically before IMQ application. Treatment significantly reduced the spleen weight to body weight ratio compared with the IMQ-treated group.
| Endpoint | Reported result | Reference |
|---|---|---|
| ratio of the spleen weight to body weight | Reported result 0.05% CP: CP significantly reduced the spleen index in IMQ-treated mice (p < 0.05) | [1] |
Conditions shared by the study groups
- Route
- topically applied
- Treatment course
- for 1 h before IMQ application
- Vehicle
- acetone
| Group / dose | Comparator | Observed result | Reference |
|---|---|---|---|
| Clobetasol propionate 0.05% | IMQ-treated (IMQ) | 0.05% CP: CP significantly reduced the spleen index in IMQ-treated mice (p < 0.05) | [1] |
- Clobetasol propionate 0.05%
- Model: BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group
Methods and source locations
Compound reported in the paper: Clobetasol propionate
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S1, S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S67, S70, S71, S74, S75, S81); Figure 1 legend (S140, S141)
ratio of the spleen weight to body weight: ratio of the spleen weight to body weight; comparator: IMQ-treated (IMQ) — 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71, S81)
Clobetasol propionate 0.05% · 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71, S75)